Researcher

Meng Xie

School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China. Electronic address: xiemeng@ujs.edu.cn.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 4, 2026 · JOURNAL ARTICLE

A brain-targeted biomimetic iron-porphyrin covalent organic framework nanoplatform for Alzheimer's disease: synergistic intervention via antioxidant, Aβ-regulating and immunomodulatory effects.

Journal of Colloid and Interface Science

Preclinical in vitro and transgenic mouse study of a novel nanoplatform without human data, efficacy metrics, or comparison to standard-of-care controls; demonstrates proof-of-concept but requires clinical translation.

PreliminaryNanoparticles Alzheimer Disease Fengmei Yang

Reported

Copper-ion chelation rate41.78%

JUL 13, 2026 · JOURNAL ARTICLE

RVG-functionalized microglial membrane-coated cerium-gallic acid metal-organic frameworks for multi-target Alzheimer's therapy.

Journal of Colloid and Interface Science

Preclinical study demonstrating in vitro efficacy and early-stage animal model results with a novel nanotherapeutic, but lacking human trials, controlled comparators, or quantified efficacy metrics.

PreliminaryAlzheimer Disease Fengmei Yang Ruixin Zhao

Study details

DesignPreclinical in vitro and in vivo (transgeni…

InterventionCeGA-MOF/B/R: cerium-gallic acid bio-metal-…